These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7940930)
1. Cyclosporine Neoral in liver transplant recipients. Levy G; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K; Grant D Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930 [No Abstract] [Full Text] [Related]
2. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related]
3. Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin A. Atkison PR; Grant DR; Williams SE; Howard J; Wall WJ; Stiller CR Transplant Proc; 1994 Oct; 26(5):2953-4. PubMed ID: 7940931 [No Abstract] [Full Text] [Related]
4. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group. Grant D; Rochon J; Levy G Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208 [No Abstract] [Full Text] [Related]
5. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection. Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845 [No Abstract] [Full Text] [Related]
6. Optimal immunosuppressive clinical regimen in liver transplantation. Farges O; Samuel D; Bismuth H Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838 [No Abstract] [Full Text] [Related]
7. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
8. Cyclosporine neoral in liver transplant recipients. Levy G; Altraif I; Rezieg M; Asfar S; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K Transplant Proc; 1994 Dec; 26(6):3184-7. PubMed ID: 7998109 [No Abstract] [Full Text] [Related]
9. OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients. Sommerauer JF; Atkison P; Howard J; Grant D; Wall W Transplant Proc; 1994 Feb; 26(1):154-6. PubMed ID: 8108917 [No Abstract] [Full Text] [Related]
10. Immunosuppressive requirements for small bowel/liver transplantation. McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086 [No Abstract] [Full Text] [Related]
11. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group. Niese D Transplant Proc; 1995 Apr; 27(2):1849-56. PubMed ID: 7725531 [No Abstract] [Full Text] [Related]
12. Late acute rejection in renal transplant recipients: response to steroid treatment. Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312 [No Abstract] [Full Text] [Related]
13. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application? Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211 [No Abstract] [Full Text] [Related]
14. Conversion from cyclosporine Sandimmun to cyclosporine neoral in liver transplant patients with cholestasis or external biliary drainage. Farges O; Haddad N; Girault D; Cabiac MD; Samuel D; Bismuth H Transplant Proc; 1995 Aug; 27(4):2506-7. PubMed ID: 7652905 [No Abstract] [Full Text] [Related]
15. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation. Chen M; Wade J; Levy GA; Greig PD Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844 [No Abstract] [Full Text] [Related]
16. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154 [No Abstract] [Full Text] [Related]
17. Immunosuppression is not related to the response to steroids in acute liver rejection. Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830 [No Abstract] [Full Text] [Related]
18. Enhanced absorption of new oral cyclosporin microemulsion formulation, Neoral, in liver transplant recipients with external biliary diversion. Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV Transplant Proc; 1994 Oct; 26(5):2977-8. PubMed ID: 7940939 [No Abstract] [Full Text] [Related]
19. Potential for CsA-Neoral in organ transplantation. Levy G; Grant D Transplant Proc; 1994 Oct; 26(5):2932-4. PubMed ID: 7940926 [No Abstract] [Full Text] [Related]
20. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients. Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302 [No Abstract] [Full Text] [Related] [Next] [New Search]